Elanco更新了《Q3 2024收入指南》,其EPS和收入低于共识估计数。 Elanco updates Q3 2024 earnings guidance with lower EPS and revenue than consensus estimates.
Elanco动物健康(NYSE:ELAN)更新了Q3 2024收入指南,预测EPS为0.090-0.140,收入为1.0-1.1B,低于协商一致的估计数。 Elanco Animal Health (NYSE: ELAN) updated its Q3 2024 earnings guidance, predicting an EPS of 0.090-0.140 and revenue of $1.0-$1.1B, lower than consensus estimates. Elanco的2024财政年度指南更新为0.880-0.960 EPS。 Elanco's FY 2024 guidance was updated to 0.880-0.960 EPS. 该公司提供宠物和农场动物保健产品,其股票价格在星期五上涨到13.04美元,交易额为4.9M股。 The company, which offers pet and farm animal health products, saw its stock price increase to $13.04 on Friday with a trading volume of 4.9M shares. Elanco的共识评级是中度购买,目标价格为17.57美元。 Elanco's consensus rating is Moderate Buy, with a target price of $17.57.